DELINAH ANDERSON: Open Payments
NPI 1518912187 · AUBURN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,409 in 67 payments from 15 companies in 2025. Trend: 2023 $875 · 2024 $1,183 · 2025 $1,409
Food & beverage: $1,409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $289 |
| ABBVIE INC. | 15 | $241 |
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $167 |
| Lilly USA, LLC | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| PFIZER INC. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Exact Sciences Corporation | 2 | $54 |
| Bioventus LLC | 1 | $38 |
Products named: Ozempic, Kerendia, QULIPTA, FARXIGA, MOUNJARO, REXULTI, ELIQUIS, UBRELVY.
Industry payments across MI — which companies pay providers there.
